Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Patients with cutaneous lupus erythematosus have a higher risk of skin cancer and other cancers.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.

DNA profiling in forensics has improved, but predicting physical traits and ancestry from DNA has limitations and requires ethical consideration.

Periodontal ligament stem cells show promise for regrowing tissues but require more research for safe, effective use.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Hair loss risk is influenced by multiple genes.

Cured meats in Nigeria have high cadmium levels, posing health risks.

B6J mice live longer before 24 months, but B6N mice live longer after; both strains show weight gain, increased food and water intake, and health issues as they age.

A new rat strain with a specific gene mutation causes hair loss and kidney issues.

Newly found stem cells in horse hooves show promise for treating a hoof disease called laminitis.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Stem cells play a key role in nonmelanoma skin cancers, with different origins and genetic changes linked to basal and squamous cell carcinomas.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Targeting colon cancer stem cells might lead to better treatment results.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Regular endoscopic checks are crucial for Cronkhite-Canada syndrome patients to catch potential cancers early.

Clouston syndrome can lead to skin cancer, so monitoring is crucial.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Most U.S. keratinocyte carcinoma patients are older white males living in urban areas.

Blocking both main energy pathways can stop hair follicle stem cell-induced skin cancer growth.

Lymphoma should be considered in unusual scalp hair loss cases, as treatment can work but may lead to severe complications.

The treatment was ineffective in humans.

Cancer-associated fibroblasts promote tumor growth in skin cancer.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

A rare ovarian tumor was successfully treated with surgery and chemotherapy.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.